US levies on drug imports may cost Indian cos $2.25 bn
mumbai, Feb. 20 -- The sword of import tariffs wielded by US President Donald Trump has sent investors and markets scurrying for cover across the world and across industries. On Wednesday, it was the turn of the pharmaceutical industry....
To read the full article or to get the complete feed from this publication, please
Contact Us.